Header Logo

Connection

David Hoaglin to Epstein-Barr Virus Nuclear Antigens

Back to Details
This is a "connection" page, showing publications David Hoaglin has written about Epstein-Barr Virus Nuclear Antigens.
David Hoaglin
Connection Strength
0.055
Epstein-Barr Virus Nuclear Antigens
  1. Bose A, Khalighinejad F, Hoaglin DC, Hemond CC. Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic Review. Mult Scler Relat Disord. 2024 Apr; 84:105410.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.